
("
Proposed Reduction of Capital and Notice of General Meeting
The proposed reduction of capital, if approved, would create distributable reserves that would give the Company further flexibility to deliver shareholder returns over the coming years either in the form of distributions and/or purchases of the Company's own shares.
The reduction of capital process comprises: (i) the proposed cancellation of the entire amount standing to the credit of the Company's share premium account (the "Share Premium Reduction"); and (ii) the proposed capitalisation of the entire amount standing to the credit of the Company's merger reserve by issuing B Ordinary Shares in the capital of the Company and the subsequent cancellation of such B Ordinary Shares (the "Merger Reserve Reduction"). The Share Premium Reduction and the Merger Reserve Reduction together comprise the "Reduction of Capital".
The Reduction of Capital is conditional upon the passing by the Company's shareholders of the resolutions set out in the Notice of General Meeting, as well as confirmation being obtained from the
The Reduction of Capital, if approved by shareholders and confirmed by the Court, is expected to create additional distributable reserves of
The Circular (including the Notice of General Meeting) will shortly be available for viewing on the Company's website at www.thecranewaregroup.com
EXPECTED TIMETABLE OF PRINCIPAL EVENTS
Publication of the Circular
|
|
Latest time and date for receipt of Forms of Proxy
|
|
General Meeting
|
|
Expected date of the first Court hearing for initial directions
|
in or around late |
Capital Reduction Record Time |
preceding the Court hearing to confirm the Reduction of Capital |
Expected date of the second Court hearing to confirm the Reduction of Capital
|
in or around |
Effective Date of the Reduction of Capital |
Business Day after the Court order confirming the Reduction of Capital |
Notes: Each of the times and dates, as set out in the Expected Timetable of Principal Events above, is based on current expectations and is subject to change. If any of the above times and/or dates is changed, the revised times and/or dates will be notified to Shareholders by announcement through a regulatory information service. All above references to times are to
For further information, please contact:
|
+44 (0)131 550 3100 |
|
|
|
|
|
|
Alma |
+44 (0)20 3405 0205 |
|
craneware@almastrategic.com |
|
|
Peel Hunt (NOMAD and Joint Broker) |
+44 (0)20 7418 8900 |
|
|
|
|
|
+44 (0)20 7597 5970 |
|
|
|
|
Berenberg (Joint Broker) |
+44 (0)20 3207 7800 |
|
|
About
For over 25 years,
As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster-that simplify the complexities of healthcare finance and operations. What sets us apart is our unique combination of deep healthcare expertise and engineering excellence, positioning us as a strategic partner rather than just a technology provider.
Learn more at www.thecranewaregroup.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the